中国生物技术、癌症早筛领域前景广阔
” However, analysts said large-scale rollouts of early cancer screening in China require improvements in not only cancer screening technology and policy support, but also in payments, clinical applications and regulations to spur the commercialization of related products. 然而,分析人士表示,中国大规模开展早癌筛查不仅需要改进癌症筛查技术和政策支持,还需要完善支付、临床应用和监管,以推动相关产品的商业化